Thomas G. Aigner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas G. Aigner has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Mortimer Mishkin
Laboratory of Neuropsychology, National Institute of Mental Health, Bethesda, MD 20892-4415
1 shared publicationNobuya Matsuoka
Laboratory of Neuropsychology, National Institute of Mental Health, Bethesda, MD 20892, USA
1 shared publicationYi Tang
Laboratory of Neuropsychology, National Institute of Mental Health, Bethesda, MD 20892-4415, USA
1 shared publication
Latest Publications
- Open Access
- 11 November 1997
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 94 (23) , 12667-12669
Effects of muscarinic blockade in perirhinal cortex during visual recognition
Stimulus recognition in monkeys is severely impaired by destruction or dysfunction of the perirhinal cortex and also by systemic administration of the cholinergic-muscarinic receptor blocker, scopolamine. These two effects are shown here to be linked: Stimulus recognition was found to be significantly impaired after bilateral microinjection of scopolamine directly into the perirhinal cortex, but not after equivalent injections into the laterally adjacent visual area TE or into the dentate gyrus of the overlying hippocampal formation. The results suggest that the formation of stimulus memories depends critically on cholinergic-muscarinic activation of the perirhinal area, providing a new clue to how stimulus representations are stored.
- 11 November 1997
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 94 (23) , 12667-12669
Open AccessEffects of muscarinic blockade in perirhinal cortex during visual recognition
Stimulus recognition in monkeys is severely impaired by destruction or dysfunction of the perirhinal cortex and also by systemic administration of the cholinergic-muscarinic receptor blocker, scopolamine. These two effects are shown here to be linked: Stimulus recognition was found to be significantly impaired after bilateral microinjection of scopolamine directly into the perirhinal cortex, but not after equivalent injections into the laterally adjacent visual area TE or into the dentate gyrus of the overlying hippocampal formation. The results suggest that the formation of stimulus memories depends critically on cholinergic-muscarinic activation of the perirhinal area, providing a new clue to how stimulus representations are stored.
- 26 August 1996
- Published by Elsevier in Brain Research
- Vol. 731 (1-2) , 72-78
The glycine/NMDA receptor antagonist HA-966 impairs visual recognition memory in rhesus monkeys
- 26 August 1996
- Published by Elsevier in Brain Research
- Vol. 731 (1-2) , 72-78
The glycine/NMDA receptor antagonist HA-966 impairs visual recognition memory in rhesus monkeys